Australian Technical Advisory Group on Immunisation (ATAGI)
State and Territory information:
The Australian Technical Advisory Group on Immunisation provides advice to the Minister for Health and Ageing on the Immunise Australia Program and other related issues. In addition to technical experts, ATAGI’s membership includes a consumer and general practitioners.
ATAGI Forum (username and password required)
New national immunisation advisory structures
Legislative changes
National Vaccine Schedule
ATAGI Bulletins
ATAGI Terms of Reference
New national immunisation advisory structures
As part of the 2005 Federal Budget, the Australian Government announced changes to immunisation policy advisory structures. The National Immunisation Advisory Structures flowchart (PDF 289 KB), from the 10th Immunisation Conference held in July 2006 (Public Health Association of Australia), outlines the changes and progress made with implementing them.Legislative changes
The National Health Act 1953 has been changed to give the Pharmaceutical Benefits Advisory Committee (PBAC)(Department of Health and Ageing) responsibility for advising the government on the funding of vaccines under the National Immunisation Program. For more information see the National Health Amendment (Immunisation Program) Bill 2005 (Australian Parliament House Library).The legislative instrument arising from this change, called National Health (Immunisation Programs - Designated Vaccines) Determination 2005, can be found on the Federal Register of Legislative Instruments (ComLaw).
The PBS and its processes presentation from the 10th Immunisation Conference held in July 2006 (Public Health Association of Australia), provides an outline of the new PBS process, following changes to the National Health Act 1953.
National Vaccine Schedule
The National Vaccine Schedule provides a list of all currently funded vaccines available under the National Immunisation Program. States and Territories may choose whatever combination of vaccines from this list as best suits the needs of geographic and demographic conditions. The ages at which diseases protected against by these vaccines should be given can be found in the National Immunisation Program Schedule (NIPS).ATAGI Bulletins
]ATAGI Bulletin 37th Meeting: 5-6 June 2008Abstract: Summary of outcomes of the meeting.
Updated: June 2008
ATAGI Bulletin 36th Meeting: 7-8 February 2008
Abstract: Summary of outcomes of the meeting.
Updated: February 2008
ATAGI Bulletin 35th Meeting: 4-5 October 2007
Abstract: Summary of outcomes of the meeting.
Updated: October 2007
ATAGI Bulletin 34th Meeting: 7-8 June 2007
Abstract: Summary of outcomes of the meeting.
Updated: June 2007
ATAGI Bulletin 33rd Meeting: 8-9 February 2007
Abstract: Summary of outcomes of the meeting.
Updated: May 2007
ATAGI Bulletin 32nd Meeting: 5-6 October 2006
Abstract: Summary of outcomes of the meeting.
Updated: November 2006
ATAGI Bulletin 31st Meeting: 7-8 June 2006
Abstract: Summary of outcomes of the meeting.
Updated: November 2006
ATAGI Bulletin 30th Meeting: 9-10 February 2006
Abstract: Summary of outcomes of the meeting.
Updated: March 2006
ATAGI Bulletin 29th Meeting: 24-25 November 2005
Abstract: Summary of outcomes of the meeting.
Updated: March 2006
ATAGI Terms of Reference
The Terms of Reference of the Australian Technical Advisory Group on Immunisation (ATAGI) are to:- Provide technical advice to the Minister for Health and Ageing on the medical administration of vaccines available in Australia, including those on the National Immunisation Program;
- Advise the Pharmaceutical Benefits Advisory Committee on matters relating to the ongoing strength of evidence pertaining to existing, new and emerging vaccines in relation to their effectiveness and use in Australian populations;
- Produce the Australian Immunisation Handbook for the approval of the National Health and Medical Research Council;
- Consult with the National Immunisation Committee (NIC) on the content and format of the Australian Immunisation Handbook and implementation strategies; and
- Consult with the Communicable Diseases Network Australia (CDNA), the Australian Drug Evaluation Committee (ADEC) and the Adverse Drug Reactions Advisory Committee (ADRAC) on matters relating to the implementation of immunisation policies, procedures and vaccine safety.
Page last modified: 25 June, 2008